• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Gangwal Healthcare is powered by innovation, driving health, wellness & healing.

    Lonza signs manufacturing agreement with Oasmia for ovarian cancer drug

    REUTERS

    Kazia Licenses Cantrixil, a Clinical-stage Ovarian Cancer Drug, to Oasmia

    PRNASIA

    Oasmia acquires rights to cancer drug candidate Cantrixil in $44m deal

    PHARMAFILE

    Oasmia AB Signs Phase 1b Trial Agreement with SAKK, The Swiss Group

    PRESS RELEASE

    Oasmia Pharmaceutical announces poster presentation at ASCO

    PRESS RELEASE

    Oasmia announces outcome of review to deliver long-term, profitable growth

    PRESS RELEASE

    Oasmia receives upfront payment of 20 MUSD from Elevar

    PRESS RELEASE

    Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.